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Polymericnanogels area class ofnanocarrier systemsbased
on biodegradable polymers that can be applied in drug
sustained release. These systems display prolonged blood
circulation time, enhanced drug solubility and selective
accumulation at tumour tissues by enhanced permeability
and retention (EPR) effect.[1,2]Hyaluronic acid (HyA) is a natural polysaccharide
composed of disaccharide units of D-glucuronic acid and
N-acetyl-D-glucosamine with b(1,4) and b(1,3) glucosidic
bonds, ubiquitous on the human body.[3,4] It is a highly
hydrophilic polysaccharide with great potential as a
drug carrier due to its physicochemical and biological
properties, such as biocompatibility, biodegradability and
non-immunogenicity.[1] Also, HyA allows several chemical
modifications including ones that can originate amphi-
philic materials capable of self-assembling into nano-
structures. Moreover, hyaladherins—a group of high
affinity HyA proteins—that include the receptor for
hyaluronan-mediated motility (RHAMM) and the HyA
receptor CD44, among others, are important mediators of
cancer development and detection. HyA exhibits specific
affinity for various cancer cells that overexpress HyA
receptors and therefore have great potential for tumour
targeting.[1,5,6]DOI: 10.1002/mabi.201400135
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improvenanogel features. The cross-linkingofnanocarriers
could take place on the hydrophilic shell,[7] within the
hydrophobic core[8,9] or at the core–shell interface.[10] Redox
sensitive nanogel usually containing dissulfide bounds
have been used to trigger burst release in response to redox
environments. Disulfide bonds represent an interesting
approach once though they are stable in the extracellular
compartments, may be prone to rapid cleavage with
intracellular reducing molecules. Tumour tissues unveil
highly reducing ambiences compared with normal ones,
with high concentrations of glutathione—a redox
molecule.[11]
Inthepresentwork,wedevelopedanewamphiphilicHyA
conjugate by grafting a thiolated hydrophobic chain by
amide bond formation, yielding hyaluronic acid—11-Ami-
no-1-undecanethiol hydrochloride (HyA-AT).We studied the
self-assembly of the HyA-AT in aqueous environment by 1H
nuclear magnetic resonance (NMR) and fluorescence spec-
troscopywithNile red,asfluorescentprobe.Thepropertiesof
the resulting nanogel were characterized as to—structure,
size, shape, zeta potential, stability and the ability to entrap
small hydrophobic molecules and by 1H NMR, fluorescence,
cryo-field emission scanning electron microscopy (cryo-
FESEM), dynamic light scattering (DLS) and SAX analysis.
Further, the engineered nanogel was crosslinked by
dissulfide bond with a homofunctional crosslinker—1,4-
Bis(3-[2-pyridyldithio]propionamido)butane (DPDPB) and
its—size, structure, stability and ability to entrap hydropho-
bic drugs was also studied.Scheme 1. Representative illustrations of HyA-AT conjugate synthesis,
reaction.
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All reagents were of analytical grade. Sodium hyaluronate
(MW¼ 7.46 kDa) was purchased from Lifecore Biomedical
(USA). AG 50W—X8 resin was purchased from Bio-Rad
(USA). Absolute ethanol was purchased from Apllichem
(Germany). Dimethyl sulfoxide (DMSO), tetrabutylammo-
nium fluoride hydrate (TBA-F), 11-amino-1-undecanethiol
hydrochloride (AT), N-hydroxysulfosuccinimide (NHS), 1-
ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochlo-
ride (EDC), 1,4-Bis(3-[2-pyridyldithio]propionamido)butane
(DPDPB) were purchased from Sigma–Aldrich (Italy). The
water used for nanogel synthesis and characterizationwas
distillated and ultrapurified (Milli-Q).3. Methods
3.1. Synthesis of Amphiphilic Hyaluronic Acid
Conjugate
Sodium hyaluronate was chemically grafted with a long
thiolated alkyl chain by amide bond formation to produce
an amphiphilic conjugate, as presented in Scheme 1.[2,12–14]
To render sodium hyaluronate soluble in DMSO, the
sodium ions of HyA were exchanged with the lipophilic
tetrabutylammonium (TBA) ion as described byOudshoorn
et al..[15] Ion exchange was performed using AG 50W-X8
cation exchange resin. AG 50W (1 g) resin was incubated
with an excess of TBA-F (3.5 g) in ultrapure water for 1h ata) ion exchange of sodium hyaluronate and b) amide bond formation
14, 14, 1556–1568
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1558room temperature and mild agitation. The resin was
elutriated, washed and transferred into a 1% (w/v) HyA
solution in ultrapure water. The exchange of the TBA ions
on the resin and the sodium ions of HyA was performed
at room temperature with agitation, for 2h. The removal
of the resin was achieved by centrifugation for 2min
at 5000 rpm (SIGMA 113 centrifuge). The resulting
HyA-TBA solution was lyophilized and the fluffy white
material was stored at room temperature. 1H NMR
spectroscopy was performed to confirm the Naþ ions
exchange with TBA-F.
Hydrophobic 11-amino-1-undecanethiol hydrochloride
(AT) was chemically conjugated to the backbone of
modified HyA-TBA in the presence of EDC and NHS. HyA-
TBA (260mg)wasdissolved inanhydrousDMSOat1%(w/v)
and EDC (100mg) and NHS (50mg) were added. Finally, AT
(15mg), also dissolved in anhydrous DMSO was added to
the reaction mixture, which was stirred for 24h at room
temperature. The resulting solution was dialyzed (MWCO
¼ 1 000Da) first against aNaCl 150mMsolution for 3 d—to
exchange again the TBA ions for sodium ions—and then
distilledwater for 2 d. Finally, the solutionwas freeze-dried
and a white cottonymaterial was obtained, corresponding
to the HyA-AT conjugate. The degree of substitution of AT
molecules in the HyA chain was determined by 1H NMR
spectroscopy.
The 1H NMR spectra were obtained using a Varian
Unity Plus 300 spectrometer operating at 299.94MHz
and 25 8C.The samples were prepared at 10.0mgmL1
in D2O.3.2. Nanogel Assembly Characterization
3.2.1. Preparation of Nanogel Dispersion
The sampleswere dispersed in distilledwater at 1.0mgmL1
and filtered through a membrane of 0.22mm pore size and
stored at 4 8C for up to 6 months.
3.2.2. Dynamic Light Scattering (DLS) Characterization
The obtained nanogel was characterized as to its size
distribution (diameter) and zeta potential by DLS
analysis (Zetasizer Nano ZS, Malvern Instruments) at
25 8C. Nanogel dispersion (1.0mL) was analysed in a
polystyrene cell or in a folded capillary cell, for size and
volume distribution or zeta potential measurements,
respectively, using a He-Ne gas laser (wavelength of
633 nm) and a detector angle of 1738. The results
presented represent the mean values of polydispersity
index (PdI), hydrodynamic diameter and zeta potential of
the particles, obtained after five repeatedmeasurements.
The Zeta potential values were calculated using Henry’s
equation.Macromol. Biosci. 201
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(Cryo-FESEM)
HyA-AT nanogel, 1.0mgmL1 concentrationwas dispersed
at indistilledwater and frozen in liquidnitrogenat200 8C.
The sample was transferred to the cryo stage (Gatan, Alto
2500, UK) of an electronmicroscope (SEM/EDS: FESEM JEOL
JSM6301F/Oxford Inca Energy 350). Sample was then
fractured and sublimated for 10 minutes at 95 8C to
remove the superficial ice layer and allow the nanogel to be
exposed. Finally, the sample was sputter-coated with gold
and palladium at 140 8C using an accelerating voltage
of 10 kV. The observation was performed at 140 8C
and 15kV.
3.2.4. Fluorescence Spectroscopy
The critical aggregation concentration (cac) of HyA-AT
nanogel was determined fluorometrically resorting to a
hydrophobic probe -Nile Red (NR). Nile red is a hydrophobic
fluorescent probe whose fluorescence intensity shifts
according to the polarity of the environment. The lyophi-
lized nanogel was dispersed in water in a range of
concentrations between 50 and 1.0mgmL1 (final volume
of 1ml), by consecutive dilutions. A stock solution of
4.0 105 M solution of NR in ethanol was prepared, and
5mL this solution was added to each sample, resulting in a
final concentration of NR of 2.0 107M and an ethanol
content of 0.5%. The samples were agitated overnight at
room temperature for homogenisation. Samples fluores-
cence spectrum were analysed in a Spex Fluorolog 3
spectrofluorimeter at room temperature. The cac was
determined by the maximum emission shift of NR and
the change of the fluorescence intensity as a function of
HyA-AT nanogel concentration.3.2.5. SAXS Experiment
SAXS experiment was carried at the European Synchro-
tron Radiation Facility (Grenoble, France) on the BM2-
D2AM beamline. Nanogel samples were set in silica
tubes (external diameter 3mm, wall thickness 0.2mm,
76mm long, from Deutero GmbH) with elastomer
closure caps to avoid water evaporation (Deutero GmbH).
The incidence photon energy was 16 000 keV and a
2D CCD X-ray detector (Ropper Scientific) was used. The
images were corrected for camera distortion, dark
image reading and flat field response of the detector.
Finally, the image center (‘‘gravity center’’ of the incident
beam) was determined with attenuators and radial
averages yielded 1D profiles (processing carried on
the beamline, with bm2img software). Silver behenate
powder was used as standard for calibration. The
scattering contribution was eliminated by subtracting
the attenuation coefficient of water filled glass tube.4, 14, 1556–1568
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and 30.0mgmL1 concentration.3.3. DPDPB Mediated Crosslinking
3.3.1. Crosslinked Nanogel Synthesis
1,4-Bis(3-[2-pyridyldithio]propionamido)butane (DPDPB),
is a homobifunctional crosslinking agent that contains
dithiopyridylgroupsonbothendsof themolecule that react
with free sulfhydryl groups.
Lyophilized HyA-AT was dispersed in water at a
concentration of 1.0mgmL1 as described earlier. As
reported by Wittrup, 2012,[17] a 10mgmL1 stock solution
of DPDPB in DMSOwas prepared and added to the nanogel
dispersion at a molar ratio of 2:1 free sulfhydryl groups of
HyA-AT conjugate. The amount of DMSO in the reaction
was inferior to 1% (v/v). Air was injected through a syringe
in the reaction mixture for 15min. Then, the suspension
was gently stirred overnight at 30 8C.
The reaction was then dialyzed against water in an
MWCO¼ 1 kDamembrane bag. The resulting solution was
freeze-dried and lyophilized.
ThecrosslinkedHyA-AT-DPDPBnanogelwasanalysedby
1H NMR spectroscopy using a Varian Unity Plus 300
spectrometer operating at 299.94MHz and 25 8C.3.3.2. Crosslinked Nanogel Characterization
3.3.2.1. UV–Vis Spectroscopy
The successful disulfide linkage between DPDPB and free
sulfhydryl groups of HyA-AT nanogel causes a shift of the
DPDPBabsorbancepeaksof 237nm(e¼ 1.2 104M1 cm1)
to272nmand thepeakat287nm(e¼ 8.8 103M1 cm1) is
shifted to 343nm (e¼ 8.08 0.3 103 M1cm1).[18] There-
fore, UV–Vis absorption spectra of a 200mL sample of the
HyA-AT-DPDPB reaction mixture was recorded on a JASCO
V560equipment.AcontrolwithunreactedDPDPBmolecule
dispersed in DMSO at a concentration of 0.2mgmL1 was
also analysed. The dialysed suspensionwas again analysed
by UV–Vis spectroscopy to ascertain the elimination of the
two pyridine-2-thione a product of the DPDPB conjugation
with AT and responsible for the 343nm peak.3.3.2.2. Cryo-Field-Emission Scanning Electron Microscopy
(Cryo-FESEM)
HyA-AT-DPDPB nanogel was dispersed at a concentration
of 1.0mgmL1 in distilled water and frozen in liquid
nitrogen at 200 8C. The sample were analysed in an
electron microscope (SEM/EDS: FESEM JEOL JSM6301F/
Oxford Inca Energy 350) as described earlier.Macromol. Biosci. 20
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The lyophilized crosslinked nanogel (HyA-AT-DPDPB)were
dispersed in distilled water at 1.0mgmL1 and filtered
through a 0.22mmmembrane pore and diluted sequential-
ly to a concentration of 1.0mgmL1. The solutions were
then characterized as to its hydrodynamic size diameter by
DLS analysis (Zetasizer Nano ZS, Malvern Instruments) at
258. The values presented represent the mean values of
PdI and size diameter of particles after five repeated
measurements.
3.3.3. Redox Sensitive Crosslinked Nanogel
Characterization
To assess the susceptibility of crosslinked nanogel to
reducing environment that disrupt dissulfide bonds, more
diluted sample of HyA-AT-DPDPB nanogel—1.0mgmL1—
was further treated with dithiothreitol (DTT), a potent
reducingagent.DTTwasused to reduce thedissulfidebonds
between DPDPBmolecules and AT residues of the HyA-AT-
DPDPB nanogel. To the HyA-AT-DPDPB solution with
1.0mgmL1 in distilled water, a DTT stock solution in
DMSO was added, to a final concentration of 1.0mM. The
final solution was stirred and incubated for 30min. The
samplewas characterized as to its hydrodynamic diameter
byDLS analysis soonafter preparation and twoweeks after,
to assess its stability under redox conditions. The values
presented represent themeanvalues of PdI and diameter of
particles after five repeated measurements.3.4. Drug Loading Efficiency
Curcumin (CM) is a hydrophobic drug insoluble in aqueous
solvents but soluble in organic ones. Simvastatin (SV) is
also a hydrophobic drug poorly soluble in water (>mgL1)
and soluble in organic solvents (PubChem Substance
and Compound database, substance identifier number
SID:54454).[19] Curcumin was solubilized in ethanol at a
concentration of 1.0mgmL1 as a stock solution. A volume
of 10mL of the curcumin stock solutionwas incubatedwith
1.0mgmL1 nanogel dispersions of HyA-AT and HyA-AT-
DPDPB, prepared as described earlier. The final curcumin
concentration attained in the samples was 30mM and the
ethanol content was 1% (v/v). In a similar way, a 5.0mg
mL1 stock solution of ethanol solubilized SVwas prepared
and 6.0mL were added to analogous nanogel samples. The
final SV concentration in the samples was 71.7mM and
the ethanol contentwas less than 1% (v/v). Also, a negative
control and a positive control of drug loading were
performed in the same volume and with the same final
concentration, in water and ethanol, respectively. The
samples were incubated overnight at room temperature in
a turningwheel. Finally, all the sampleswere centrifugedat14, 14, 1556–1568
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156013 000 rpm (SIGMA 113 centrifuge) for 10min to remove
the insoluble drugs. The samples supernatant were
analysed in a JASCO V560 system and the UV–Vis
absorption spectra was recorded. Soluble CM has a yellow
tone colour and amaximumabsorbance at 428nm. Soluble
SV is a colourless solution with maximum absorbance at
238 and 247nm.4. Results
4.1. Synthesis of Amphiphilic Hyaluronic Acid
Conjugate
Amphiphilic hyaluronic acid conjugate was synthetized
as shown in Scheme 1a. Sodium hyaluronate was first
converted to its tetrabutylammonium salt to enhance the
solubility in polar aprotic organic solvents. The exchange
with the lipophilic cationwas confirmed by 1HNMR inD2O
by the peaks at d¼ 0.97 (m, 12H, Nþ—[(CH2)3—CH3]4);
d¼ 1.40 (m,8H,Nþ—[(CH2—CH2—CH2—CH3]4); d¼ 1.64 (m,
8H, Nþ—[(CH2—CH2—CH2—CH3]4) and d¼ 3.82 (m, 8H,
Nþ—[(CH2—CH2—CH2—CH3]4).
[20] The degree of substitu-
tion (DS) of the sodium ion by the tetrabutylammoniumFigure 1. 1H NMR spectrum of HyA-AT nanogel in D2O at 25 8C and a
Macromol. Biosci. 201
 2014 WILEY-VCH Verlag GmbHion, defined, as the number of TBA molecules per 100
residuesofHyA,wascalculatedbasedonthe1HNMRinD2O
of HyA-TBA. The DS obtained for different batches was
reproducible and approximately 100%.
Further conjugation of hyaluronate TBA salt with 11-
Amino-1-undecanethiol (AT) by amidebond formationwas
performed as shown in Scheme 1b. The amino group of AT
reactedwith the carboxylic groups of hyaluronic acid in the
presence of 1-ethyl-3(3-dimethylaminopropyl)carbodii-
mide (EDC) and N-hydroxysuccinimide (NHS) through
carbodiimide chemistry. The grafting of the hydrophobic
chain and the respective DS, defined as the number of AT
molecules per 100 disaccharide units of HyA, were
confirmed by 1H NMR spectroscopy, as shown in Figure 1.
The assignments and chemical shifts of the 1H signals in
D2O used in the determination of the DS are indicated in
Figure1.Thepeakscorrespondent tohyaluronicacidused to
the calculus are assigned to 11 protons—and are identified
in Figure 1, with the number 2—which are: d¼ 4.51 (G1),
d¼ 4.61 (N1), d¼ 3.92 (N2), d¼ 3.63 (G3), d¼ 3.74–3.85 (N3,
N6, G4, G5) and d¼ 3.51–3.62 (N4, N5).[21] The peaks
assigned to AT protons used in the determination of the
DS are d¼ 1.2–1.4 (14Hþ, Nþ—(CH2)2—(CH2)7–(CH2)2–SH).schematic representation of the HyA-AT conjugate.
4, 14, 1556–1568
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equation:Fig
nan
www.MDSAT ¼ 14 ðd1:2! 1:4Þ
11 ðd3:51! 4:61 100The DS was about 11%, meaning that 1 out of every 11
disaccharide units are chemically modified with AT. The
yieldof the reactionwasabout67%andwas reproducible in
all batches.4.2. Nanogel Characterization
4.2.1. Dynamic Light Scattering (DLS) Characterization
The grafting of AT molecules to hydrophilic backbone of
HyA results in an amphiphilic molecule capable of self-
assembling into nanostructures in aqueous environment.
HyA-AT nanogel was fully characterized by DLS analysis
regarding its size distribution by intensity (Figure 2a) or
volume (Figure 2b) and zeta potential (Figure 2c). Size
distribution is an intensity profile in which the light
scattered by the particles is conditioned by its size. The first
order result from a DLS experiment is the intensity
distribution of particle sizes. The intensity distribution is
weighted according to the scattering intensity of each
particle fraction. As such, the intensity distribution can be
somewhat misleading, in that a small amount of aggre-
gates or larger particles can dominate the distribution.
The intensitydistribution (quite sensitive to thepresence
of larger particles) can be converted, using Mie theory, to a
volumedistribution. The conversion tovolumedistributionure 2. a) Size distribution by intensity and b) by volume and, c) ze
ogel (scale bar¼ 2mm).
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in our opinion, more realistic size distribution.
When dispersed in water at 1.0mgmL1 concentration,
the nanogel reveals a bimodal size distribution with a
smaller population around 20nm and another with about
150nm, corresponding to a mean size diameter of
80.2 0.4 nm (n¼ 5). The self-assembly of the engineered
nanogel was tested in the presence of a reducing agent—
DTT—and the resulting mean size diameter was
91.85 0.410 nm. This proves, that in this case the thiol
groups of the hydrophobic chains present in the HyA-AT
nanogel do not seem to react with one another, in a
spontaneous manner.
Nanocarriers smaller than 200nm can avoid uptake by
the mononuclear phagocyte system, the longer circulation
time allowing specific interaction with the target tis-
sues.[22] Analysing the volume distribution profile
(Figure 2b) the smallest population at 20nm represents
approximately 95% being the main population.
The polydispersity index of the nanogel size distribu-
tion was about 0.4. The zeta potential obtained for
HyA-AT nanogel was –19.3 1.97mV (n¼ 5) in average.
Negatively charged particles have demonstrated en-
hanced circulation time within the body also due to
non-specific binding to serum proteins and allowed high
storage stability owing to electrostatic repulsion between
the particles.[4,6] Also, the negative charge of the particles
confirms the presence ofHyA at the surface of the nanogel
as it was expected and is due to the ionized carboxylate
groups.
The morphology of the HyA-AT nanogel was examined
by Cryofield emission scanning electron microscope (Cryo-ta potencial of the HyA-AT nanogel. d) Cryo-FESEM image of HyA-AT
14, 14, 1556–1568
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Figure 4. Emission spectra of Nile Red in a concentration of
2.0 107 M as a function of HyA-AT nanogel concentration.
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1562FESEM) and is shown in Figure 2d. The nanogel particles
were well dispersed with spherical shape. Size and volume
distribution profiles from DLS analysis were confirmed in
the Cryo-FESEM images, where particles with size corre-
sponding to the two populations identified by DLS are
indeed visible.
4.2.2. Stability of HyA-AT Nanogel
The stability of HyA-AT nanogel was evaluated at
different pH and at 25 8C and also following incubation
for 7 d at 4 8C. In pH4 phosphate-citrate buffer, the mean
size was 112.4  10.21m (121.8 9.2 nm after 7 d at 4 8C)
and in pH 7.4 phosphate buffer saline, the mean size
was 90.1 0.419 nm (88.9 0.4nm after 7 d at 4 8C). The
nanogel dispersed in distilled water at 1.0mgmL1 was
stored up to 6 months at 4 8C and demonstrated high
stability in terms of size distribution as may be seen in
Figure 3.
4.2.3. Determination of Critical Aggregation
Concentration of the Nanogel
Critical aggregation concentration (cac) of the HyA-AT
conjugates was determined by fluorescence spectroscopy
using Nile Red (NR) as a fluorescent probe. Nile red is a
hydrophobic molecule, whose maximum fluorescent
emission wavelength is dependent of the polarity of the
surrounding environment. When transferred from non-
polar to hydrophobic environments, NR emission spec-
trum is shifted to higher wavelengths and this feature
turns it suitable to assess the cac of amphiphilic
polymers.[23,24]
For the determination of the cac of HyA-AT conjugate,
NR was added to a series of conjugate dispersions with
concentration comprised between 10.0mg L1 and 1.0 g L1.
The fluorescence emission spectra of NR at different
concentrations of HyA-AT nanogel are represented inFigure 3. Colloidal stability of HyA-AT nanogel evaluated by
average particle size (diameter-nm) of the nanogel as a
function of time.
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(solid line) and fluorescence intensity (doted line) in
Figure 5. From these results we may conclude that at
concentrations below cac, amphiphilic HyA-AT molecules
do not bear any specific organization (premicellar concen-
tration, zone A, Figure 4). Near cac, the maximum
fluorescence emissionwavelength of NR decreased abrupt-
ly fromabout 660 to 610nm (zone B, Figure 4 and 5) and the
fluorescence increases (Figure 5, doted line). These changes
indicate that the immediateenvironmentof thefluorescent
probe changed from polar to less polar due to the
interactions between NR and the AT pendant groups of
HyA-AT, organized through self-assembling at the higher
concentrations, forming hydrophobic nanodomains.
Hence, the concentration at which the amphiphilic HyA-
AT conjugate self-assembles onto nanostructures with
hydrophobic nanodomains is establish between 0.8 and
1.0mg L1. The cac reported for similar amphiphilic
materials was 0.042mgmL1 for HyA-ceramide conju-
gate,[22] 67.5mg L1 for HyA- g-all-trans retinoid acid[25]
and 37.3–10.0mgmL1 for HyA-C18 conjugate.[13] These
low cac values indicate that HyA-AT nanogel might have0.00001 0.0001 0.001 0.01 0.1 1
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Figure 5. Plot data representation of the fluorescence intensity
(*) and maximum emission wavelength (&) of Nile Red as a
function of HyA-AT concentration.
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Figure 6. SAXS analysis of HyA-AT nanogel (water dispersion) at
30.0 and 10.0mgmL1 concentrations.
Figure 7. A) Schematic representation of the crosslinking reaction bet
FESEM image of HyA-AT-DPDPB nanogel (scale bar¼ 2mm).
A Novel Crosslinked Hyaluronic Acid . . .
www.mbs-journal.de
Macromol. Biosci. 20
 2014 WILEY-VCH Verlag Gmwww.MaterialsViews.comgood dilution stability in the bloodstreams after intrave-
nous injection.[26]4.2.4. SAXS Experiments
Themorphologyand inner structure of theHyA-ATnanogel
was studied by Small Angle.
X-ray Scattering (SAXS). The scattering patterns shown
in Figure 6 demonstrate the existence of hydrophobic
nanodomains. These scattering nanodomains present a
gyration radius between 4.6 and 4.8 nm and irregular
shape, which is an expected feature since they are formed
by AT chains. For the nanogel population with lower size
(20nm), it may be speculated that each particle presents at
least one hydrophobic nanodomain, surrounded by a
hydrophilic corona. However, as observed in a work on a
similar material,[27] each nanogel particle may containween HyA-AT conjugate and DPDPB through disulfide bond. B) Cryo-
14, 14, 1556–1568
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1564several hydrophobic nanodomains, as it is quite likely the
case for the larger particles.4.3. DPDPB Mediated Crosslinking
4.3.1. Crosslinked Nanogel Synthesis
We developed an original way of reticulating the hydro-
phobic polymer chains of HyA-AT nanogel, by redox-
sensitive bonds, as represented in Figure 7. The reticulation
of thechainsofamphiphilichyaluronic acid conjugateswas
fulfilled using a homobifunctional sulfhydryl-reactive
crosslinker—1,4-Bis(3-[2-pyridyldithio]propionamido)bu-
tane (DPDPB). DPDPB reacts with the sulfhydryl groups of
AT residues releasing the two pyridine-2-thione of the
terminus of the molecule. Conjugation with DPDPB results
in a 14-atom spacer of approximately 16 A˚ in length
(Figure 7).
A 1H NMR spectrum of the crosslinked and non-cross-
linked HyA-AT nanogel was performed to confirm the
successful conjugation of DPDPB, which was indeed
confirmed by the presence of the peaks at 1.36–1.38, 1.55
and 1.85 ppm assigned to the methyl groups of DPDPB
(Figure 8).Figure 8. 1H NMR spectrum of HyA-AT-DPDPB and HyA-AT nanogels
peaks.
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4.3.2.1. UV–Vis Spectroscopy
The release of the two pyridine-2-thione during the
conjugation reaction causes the shift of the DPDPB
absorbance peaks of 237 nm (e¼ 1.2 104 M1 cm1) that
is shifted to 272 nm and the peak at 287 nm (e¼ 8.8
103 M1 cm1) that is shifted to 343 nm (e¼ 8.08 0.3
103 M1 cm1) (Hermanson, 2010). Therefore, the cou-
pling of DPDPB was confirmed by monitoring the
absorbance spectrum of DPDPB by UV–Vis spectroscopy
(JASCO V560) and the appearance of the 343 nm peak
(Figure 9).
Themonitoring of the conjugation byUV spectroscopy
was performed prior and after dialysis, once the dialysis
was intended to eliminate the released pyridine-2-
thione and the unreacted DPDPB (Figure 8). The peak
at 343 nm in the reticulated nanogel (before dialysis)
demonstrates the conjugation of DPDPB and the release
of the pyridine-2-thione (doted line, Figure 8), effectively
removed by dialysis together with the unreacted DPDPB
molecules, as proven by the withdrawal of the 343 nm
peak and the presence of the 272 nm peak (grey line,
Figure 9).in D2O at 25 8C and the evidence of the presence of DPDPB ascribed
4, 14, 1556–1568
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Figure 9. UV–Vis absorbance spectrum of HyA-AT-DPDPB
nanogel.
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Figure 11. Plot data representation of the mean size diameter of
HyA-AT and HyA-AT-DPDPB nanogel particles as function of
nanogel concentration and the effect of a reducing agent in
the crosslinked nanogel.
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(Cryo-FESEM)
HyA-AT-DPDPBnanogelwas prepared at a concentration of
1mgmL1 in distilled water, frozen and analysed in an
electron microscope (SEM/EDS: FESEM JEOL JSM6301F/
Oxford Inca Energy 350).
The Cryo-FESEM images show that the reticulated
nanogel was also spherical in shape (Figure 7).
4.3.2.3. Dynamic Light Scattering (DLS) Characterization
In Figure 10, we present the volume distribution profiles of
reticulated and non-reticulated nanogel, using samples
with concentrations between 1.0 and 0.001mgmL1—the
later, a concentration below de cac of the HyA-AT nanogel.
The non-reticulated nanogel showed stability in terms of
mean size values and volume distribution profile whenFigure 10. Comparison of hydrodynamic particle volume distributio
evaluated by DLS analysis.
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 2014 WILEY-VCH Verlag Gmwww.MaterialsViews.comdiluted to a concentration of 5mgmL1. Once further
diluted, at concentrations below the cac—1.0mgmL1—it
was possible to detect disassembling of the nanogel as seen
in the volume distribution profile and by the mean size
value (Figure 11).
The study of the dilution effect on the DPDPB-
reticulated nanogel was also performed in the same
concentration range. The volume distribution profile and
the mean size diameter of HyA-AT-DPDPB nanogel weren profile of HyA-AT and HyA-AT-DPDPB nanogels upon dilution,
14, 14, 1556–1568
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Figure 12. UV–Vis absorbance spectrum of curcumin at a 30mM
concentration solubilized in different solvents and in the
presence of HyA-AT and HyA-AT-DPDPB nanogel.
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1566analysed by DLS (Figure 10, 11). Remarkably, the nanogel
volume distribution profile and mean size was main-
tained even bellow the cac. The lower concentration—
1mgmL1—was evaluated after 2 weeks to assess the
stability and it was noticeable that the nanogel preserved
its supramolecular structure. Similar results were
obtained by other researchers.[28,29]
Interestingly, the reticulated nanogel volume distribu-
tion showed more equitable populations than in the non-
reticulated, indicating that the crosslinking caused an
increase in the larger population. This may be due to the
effect of the DPDPB spacer in the reorganization of the HyA
and AT chains that become deviated increasing the larger
population, around 150nm.
Hence, the reticulated nanogel—although with slightly
larger particles—presents a narrower distribution, demon-
strated by the smaller PdI values obtained by DLS analysis
(Figure 11).4.3.3. Redox Sensitive Crosslinked Nanogel
Characterization
Nonetheless, the more diluted sample was further treated
with dithiothreitol (DTT), a reducing agent to disrupt the
reversible DPDPB conjugation. The reducing agent recoiled
the reticulating effect of DPDPB by breaking the disulfide
bond between the 14-atomspacerwithAT residues ofHYA-
AT nanogel.220 240 260 280 300
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Figure 13. UV–Vis absorbance spectrumof simvastatin at a 71.7mM
concentration in different solvents and in the presence of HyA-AT
and HyA-AT-DPDPB nanogel.4.4. Drug Loading Efficiency
The drug entrapment efficiency of HyA-AT nanogel was
determined using curcumin and simvastatin as model
hydrophobic drugs. The encapsulation efficiency (EE) was
assessed spectrophotometrically and expressed in concen-
trationofdrug incorporated into thenanogel. Simvastatin is
a hydrophobic statin[30] used in the treatment of dyslipi-
daemias and recent findings indicate that also exhibit anti-
inflammatory properties such as inhibiting the production
of pro-inflammatory cytokines, C-reactive protein, cellular
adhesion molecules and chemotaxic molecules.[31,32] Cur-
cumin (diferuloylmethane) is a low molecular weight
natural polyphenolic compound soluble in ethanol and
insoluble inwaterwithantioxidant, anti-inflammatoryand
anticancer properties.[33] These were used as a model drug
for assessing the loading capability of HyA-AT nanogel.
Since both drugs prefer hydrophobic environments we
tested their loading onto de nanogel hydrophobic domains.
Curcumin (CM) and simvastatin (SV) exhibit strong
absorption at 428nm and at 238 and 247nm, respectively,
allowing the use of spectrophotometrical analysis to
quantify the amount of drug incorporated into the nanogel.
An ethanolic solution of curcumin (stock solution) was
added to 1.0mgmL1 nanogel aqueous suspension—finalMacromol. Biosci. 201
 2014 WILEY-VCH Verlag GmbHcurcumin concentration of 30mM—precipitation of the
(presumably) non-incorporated curcumin being observed.
The nanogel dispersion developed a bright yellow colour
characteristic of solubilized curcumin. The same dilution of
the stock-solution of curcumin was applied in an ethanol
control solution, illustrative of the maximum curcumin
loading absorption. The absorption at 428nm confirm the
curcumin loading in both the reticulated and non-reticulat-
ed nanogel samples, as seen in Figure 12, reaching
concentrations of 15.63 and 13.94mM, respectively. Similar
resultswere obtained by researcherswith PLGAnanogel.[34]
Simvastatin loadingwas performed in a similar way. An
ethanolic stock solution of simvastatin was added to
1.0mgmLnanogeldispersion, leading toafinal simvastatin
concentration of 71.7mM. In Figure 13, the characteristic
absorption of simvastatin at 238 and 247nm is detected;4, 14, 1556–1568
& Co. KGaA, Weinheim www.MaterialsViews.com
Table 1. DLS results of the hydrodynamic particles size (diameter-nm) of the HyA-AT and HyA-AT-DPDPB nanogel, before and after the drug
incorporation. Here is also described the amount of drug loaded and drug loading efficiency of the nanogels.
Sample Drug loaded Drug loading Encapsulation Efficiency Size (SD)
HyA-AT – 86.76 2.063nm
HyA-AT-DPDPB 122.2 40.70nm
HyA-AT Curcumin 13.94mM 40.46 1.5% 175.8 22.15nm
HyA-AT-DPDPB 15.63mM 52.1 1.8% 159.3 6.725nm
HyA-AT Simvastatin 11.85mgmL1 44.63 0.9% 148.2 3.563nm
HyA-AT-DPDPB 13.39mgmL1 39.5 1.2% 150.3 18.59nm
A Novel Crosslinked Hyaluronic Acid . . .
www.mbs-journal.desettling the entrapment of the hydrophobic drug by the
reticulated and non-reticulated nanogels, yielding estimat-
ed amounts of soluble simvastatin of 11.85 and 13.39mg
mL1, respectively. Similar entrapment concentrations
were obtained in other works.[25,35,36]
The effect of the drug incorporation in the size of the
nanogel was assessed by DLS analysis (Table 1). The
swelling of the non-reticulated nanogels is noticeable, as
also observedwith similarmaterials.[29,37] As expected, the
reticulated nanogel exhibited higher size stability and was
not significantly affected by the drug loading.5. Conclusion
The synthesis of a thiolated hyaluronic acid conjugate that
self-assembles into nanosized structureswas achieved in a
versatile, easy and reproducible manner. The nanogel
presented long-term stability in solution and a fairly low
critical aggregation concentration, which envisages good
behaviour upon dilution, such as in vivo administration.
The nanogel was successfully reticulated by dissulfide
bond with a homofunctional crosslinker that linked the
thiolated hydrophobic chains between them. Further,with
the effective encapsulation of hydrophobic drugs suggest
that both nanogels embody good vector systems for drug
release and may exhibit redox sensitive trigger burst drug
release.Acknowledgements: The authors would like to acknowledge the
support of FCT for the PhD grant reference SFRH/BD/61516/2009.
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